Notícias Galapagos NV - GLPG | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Galapagos NV (GLPG)
Galapagos NV (GLPG) Notícias

Galapagos NV (GLPG)

27,895

0,395

(1,44%)

Fechado 03 Janeiro 6:00PM

Atrasado por 15 minutos

27,895

-0,015

(-0,05%)

Após o horário de negociação: 7:30PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Form S-8 - Securities to be offered to employees in employee benefit plans

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from FMR LLC

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições